Protocols
1 protocol(s) meet the specified criteria
Drug: Alvocidib
Protocol No.TitleStatus
TPI-ALV-101A Phase 1, Open-label, Dose-escalation, Safety and Biomarker Prediction of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)Open